Should we question our current model for encouraging innovation in the pharmaceutical sector?
This article provides an overview of the performance of innovation policies in the pharmaceutical sector. It discusses the conditions under which various policies are most likely to result in socially valuable R&D. Interactions between different domestic policies, as well as the importance o...
שמור ב:
| מחבר ראשי: | |
|---|---|
| פורמט: | Article ou chapitre numérique |
| שפה: | Français |
| יצא לאור: |
2022
|
| גישה מקוונת: | Accès Université d'Orléans et IFPM Accès Université d'Orléans et IFPM |
| סיכום: | This article provides an overview of the performance of innovation policies in the pharmaceutical sector. It discusses the conditions under which various policies are most likely to result in socially valuable R&D. Interactions between different domestic policies, as well as the importance of considering strategic interactions between governments, are also highlighted. |
|---|